home / stock / atrc / atrc news

ATRC News and Press, AtriCure Inc. From 05/01/24

Stock Information
Company Name: AtriCure Inc.
Stock Symbol: ATRC
Market: NASDAQ
Website: atricure.com
Menu
ATRC ATRC Quote ATRC Short ATRC News ATRC Articles ATRC Message Board
Get ATRC Alerts

News, Short Squeeze, Breakout and More Instantly...
ATRC - Expected US Company Earnings on Wednesday, May 1st, 2024

Enact Holdings Inc. (ACT) is expected to report $0.99 for Q1 2024 FormFactor Inc. (FORM) is expected to report $0.09 for Q1 2024 SAAB AB - Class B (SAABF) is expected to report for quarter end 2024-03-31 Lumos Pharma Inc. (LUMO) is expected to report $-1.21 for Q1 2024 Axis Capita...
ATRC - AtriCure Q1 2024 Earnings Preview

2024-04-30 17:35:59 ET More on AtriCure AtriCure, Inc. (ATRC) Q4 2023 Earnings Call Transcript AtriCure upgraded at Oppenheimer on valuation AtriCure Q4 2023 Earnings Preview Seeking Alpha’s Quant Rating on AtriCure Historical earnings data for...

ATRC - AtriCure to Participate in the 2024 Bank of America Securities Healthcare Conference

AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that the company will be participating in the upcoming Bank of America Securi...

ATRC - AtriCure upgraded at Oppenheimer on valuation

2024-04-23 08:34:50 ET More on AtriCure AtriCure, Inc. (ATRC) Q4 2023 Earnings Call Transcript AtriCure Q4 2023 Earnings Preview Seeking Alpha’s Quant Rating on AtriCure Historical earnings data for AtriCure Financial information for AtriCure ...
ATRC - AtriCure Announces Launch of the cryoSPHERE®+ Probe for Post-Operative Pain Management

AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that it has launched the cryoSPHERE ® + cryoablation probe, leve...

ATRC - Needham sees BSX, CNMD, RMD beating Street, despite medtech slow down

2024-04-14 17:56:08 ET More on Boston Scientific, CONMED, etc. ResMed: Not A Sleeper Boston Scientific: Implications Of The Axonics-Medtronic Patent Clash Boston Scientific: The Market's Newest Mega-Cap Needs A Breather Mizuho sees ResMed as 'overwhelming ben...

ATRC - AtriCure to Announce First Quarter 2024 Financial Results

AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that it will release its first quarter 2024 financial results on Wednesday, M...
ATRC - US Companies Moving the Markets, Morning edition
Wed, Apr 03, 2024 as of 10.00 am ET

A look at the top 10 most actives in the United States Kintara Therapeutics Inc. (KTRA) rose 99.9% to $0.2007 on volume of 121,318,217 shares Next.e.GO N.V. (EGOX) rose 30.8% to $0.034 on volume of 63,981,361 shares C3is Inc. (CISS) rose 20.8% to $0.0494 on volume of 63,446,681 shares I...

ATRC - AtriCure to Participate in the 23rd Annual Needham Virtual Healthcare Conference

AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that the company will be participating in the upcoming 23rd Annual Needham Vi...

ATRC - Oppenheimer: S&P 500 top might not come until 2025; spotlights infrastructure stocks

2024-03-25 11:19:34 ET Oppenheimer argued on Monday that the S&P 500 ( SP500 ) is poised for a move higher when looking back at macro similarities from 1987 to 1990. The key takeaway from the '87-'90 road map was that the Fed’s first rate cut proceeded the top in market bread...
Previous 10 Next 10